Course Overview
MASH Unlocked: Diagnostics, Data & the New Therapeutic Era is a one-hour accredited educational program designed to improve clinician performance in the diagnosis, risk stratification, and management of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic associated steatohepatitis (MASH). Rapid advances in disease nomenclature, noninvasive diagnostics, clinical trial data, and the availability of the first FDA-approved therapy have fundamentally changed the clinical landscape.
Learning Objectives
At the conclusion of this activity, learners will be able to:
Apply updated MASLD/MASH nomenclature and noninvasive diagnostic algorithms to accurately identify and risk-stratify patients, leading to earlier intervention and appropriate referral.
Incorporate clinical trial data and FDA-approved and emerging therapies into individualized treatment plans for patients with MASH to improve fibrosis-related outcomes.
Implement practical, patient-centered management strategies—including metabolic risk modification and long-term monitoring—to optimize adherence and real-world treatment effectiveness.
Upcoming Seminars:
Tuesday, September 15
Raleigh, NC — Cucciolo Ostero
Hosted by the Triangle Gut Club
7:00 PM
Speaker: Douglas Dietrich, MD, Mount Sinai Medical Center
Wednesday, November 11
Houston, TX — Brennan's Houston
Hosted by the Harris County Academy of Family Physicians
6:30 PM
Speaker: Saira Khaderi, MD, MPH, Baylor College of Medicine